Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitor

Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an EGFR inhibitor

US Patent 10532052 · Granted Jan 14, 2020

Estimated economic value: $319,053,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for detecting protein modifications using specific antibodies2021
Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer acti2019
Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer acti2019
Cyclic amides as MetAP-2 inhibitors2018
Pyrrolidinone derivatives as MetAP-2 inhibitors2018
Piperazine derivatives as FASN inhibitors2017
Pyrido-pyrimidine derivatives2016